Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Appointed director
Quarterly results
|
|
Mirati Therapeutics, Inc. (MRTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Boxer Capital, LLC (See remarks) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Bought 57,533 shares
@ $27.8, valued at
$1.6M
Bought 1,201,440 shares
@ $27.8, valued at
$33.4M
|
|
| 08/15/2023 |
4
| Boxer Capital, LLC (See remarks) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Bought 57,533 shares
@ $27.8, valued at
$1.6M
Bought 1,201,440 shares
@ $27.8, valued at
$33.4M
|
|
| 08/14/2023 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Bought 10,791 shares
@ $27.8, valued at
$300k
|
|
| 08/10/2023 |
4
| Stelzer Laurie (CFO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 22,297 shares
@ $37, valued at
$825k
|
|
| 08/10/2023 |
4
| BAUM CHARLES M (Interim CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 54,054 shares
@ $37, valued at
$2M
|
|
| 08/10/2023 |
4
| Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 22,297 shares
@ $37, valued at
$825k
|
|
| 08/10/2023 |
4
| Moriarty John B (Chief Legal Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 22,297 shares
@ $37, valued at
$825k
|
|
| 08/10/2023 |
4
| Christensen Jamie (EVP & Chief Scientific Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 22,297 shares
@ $37, valued at
$825k
|
|
| 08/10/2023 |
4
| Sandler Alan B. (Chief Medical Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 22,297 shares
@ $37, valued at
$825k
|
|
| 06/02/2023 |
4
| Stelzer Laurie (CFO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 4,647 shares
@ $37.06, valued at
$172.2k
|
|
| 05/24/2023 |
4
| Christensen Jamie (EVP & Chief Scientific Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 619 shares
@ $45.2905, valued at
$28k
|
|
| 01/24/2023 |
4
| Davis Aaron I. (10% Owner) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 4,444 shares
@ $0
Granted 7,520 options to buy
@ $45.66, valued at
$343.4k
|
|
| 01/24/2023 |
4
| BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 4,444 shares
@ $0
Granted 7,520 options to buy
@ $45.66, valued at
$343.4k
|
|
| 01/24/2023 |
4
| Johnson Craig A (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 4,444 shares
@ $0
Granted 7,520 options to buy
@ $45.66, valued at
$343.4k
|
|
| 01/24/2023 |
4
| Cherrington Julie M (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 4,444 shares
@ $0
Granted 7,520 options to buy
@ $45.66, valued at
$343.4k
|
|
| 01/24/2023 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 6,333 shares
@ $0
Granted 10,716 options to buy
@ $45.66, valued at
$489.3k
|
|
| 01/24/2023 |
4
| Sharp Shalini (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 4,444 shares
@ $0
Granted 7,520 options to buy
@ $45.66, valued at
$343.4k
|
|
| 01/24/2023 |
4
| Christensen Jamie (EVP, Chief Scientific Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 26,864 shares
@ $0
Granted 45,456 options to buy
@ $45.66, valued at
$2.1M
|
|
| 01/24/2023 |
4
| Meek David D. (CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 89,379 shares
@ $0
Granted 151,233 options to buy
@ $45.66, valued at
$6.9M
|
|
| 01/24/2023 |
4
| Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 36,394 shares
@ $0
Granted 45,456 options to buy
@ $45.66, valued at
$2.1M
|
|
| 01/24/2023 |
4
| CARTER BRUCE L A (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 4,444 shares
@ $0
Granted 7,520 options to buy
@ $45.66, valued at
$343.4k
|
|
| 01/24/2023 |
4
| Stelzer Laurie (CFO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 26,864 shares
@ $0
Granted 45,456 options to buy
@ $45.66, valued at
$2.1M
|
|
| 01/24/2023 |
4
| FUCHS HENRY J (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 4,444 shares
@ $0
Granted 7,520 options to buy
@ $45.66, valued at
$343.4k
|
|
| 01/24/2023 |
4
| Martinez Maria E (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 4,444 shares
@ $0
Granted 7,520 options to buy
@ $45.66, valued at
$343.4k
|
|
| 01/20/2023 |
4
| Cherrington Julie M (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 2,546 shares
@ $44.66, valued at
$113.7k
|
|
| 01/19/2023 |
4
| Meek David D. (CEO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 3,179 shares
@ $42.3764, valued at
$134.7k
|
|
| 01/19/2023 |
4
| Christensen Jamie (EVP, Chief Scientific Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 1,358 shares
@ $42.3778, valued at
$57.5k
Sold 887 shares
@ $42.3821, valued at
$37.6k
|
|
| 01/19/2023 |
4
| Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 947 shares
@ $42.3779, valued at
$40.1k
Sold 619 shares
@ $42.3814, valued at
$26.2k
|
|
| 01/10/2023 |
4
| Hickey Benjamin (EVP, Chief Commercial Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 2,088 shares
@ $45.37, valued at
$94.7k
|
|
| 01/05/2023 |
4
| BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 3,648 shares
@ $46.6, valued at
$170k
|
|
| 01/05/2023 |
4
| Christensen Jamie (EVP, Chief Scientific Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 1,949 shares
@ $46.6, valued at
$90.8k
|
|
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|